FindTrial
Sign In

Integrated Research of Cancer Molecular Profiling and Drug Discovery Research Using Quantum Computing

Integrated Analysis of Cancer Molecular Profiling and Drug Discovery Research Using Quantum Computing - Q-MONSTAR_Project

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000058153
Enrollment
28500
Registered
2025-06-12
Start date
2025-03-27
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid Malignancies

Interventions

None listed

Sponsors

National Cancer Center Hospital East
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The analysis and secondary use of information obtained from the SCRUM-Japan GI MONSTAR-SCREEN Integrated Database for Biomarker Discovery in Malignant Tumours has not been refused in the relevant study.

Exclusion criteria

Exclusion criteria: The following criteria will result in exclusion from the study. 1) Data required for this study is missing. 2) The researcher determines that the participant is ineligible.

Design outcomes

Primary

MeasureTime frame
Profiles of gene variants, biomarkers,in tumor tissue, blood, stool samples, images, etc.—

Secondary

MeasureTime frame
Correlation between profiles of gene variants, biomarkers, etc. in tumour tissue, blood, stool samples, images, etc. and clinical pathological factors, clinical course, etc.—

Countries

Japan

Contacts

Public ContactMitsuho Imai

National Cancer Center Hospital East Translational Research Support office, Department Drug Development/ International Research Promotion

miim2@east.ncc.go.jp0471331111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026